INBS

INTELLIGENT BIO SOLUTIONS IN

INBS·36151G709·US·Common Stock·Healthcare - Medical Devices-13D/G

INBS (INTELLIGENT BIO SOLUTIONS IN) is held by 6 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($47,827), VANGUARD CAPITAL MANAGEMENT LLC ($13,334), UBS Group AG ($13,162). Net institutional sentiment: Mixed.

6
Holders
$84,193
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
INBS

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistARArmistice Capital, LLC5.9%Aug 14, 2026
ActivistARArmistice Capital, LLC10.0%May 15, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
20,840(-27.2%)$47,8270.0%-44.88%
0
Unchanged
5,810$13,3340.0%-44.88%
0
Increased
5,735(+1441.7%)$13,1620.0%-6.31%
19
Unchanged
3,958$9,0840.0%-44.88%
0
Unchanged
200$4600.0%-44.88%
0
New
142$3260.0%-1.53%
17
Exited
0(-100.0%)$126,9630.0%-44.02%
0
INBSINBSINTELLIGENT BIO SOLUTIONS IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used